Variant-specific dynamics of amyloid-b fibrils
淀粉样蛋白-b 原纤维的变体特异性动力学
基本信息
- 批准号:10291100
- 负责人:
- 金额:$ 46.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmyloid FibrilsAmyloid beta-ProteinAspartateBrainC-terminalCell membraneComputer ModelsDepositionDeuteriumDevelopmentDiffuseDiseaseEquilibriumGenerationsGenetic PolymorphismGoalsGrowthHydrophobicityInterventionInvestigationJointsKineticsLabelLengthLettersLightLipidsMeasurementMembraneMethodsModelingModificationMolecularMolecular ConformationMolecular StructureMorphologyMotionN-terminalNMR SpectroscopyNatureOnset of illnessPathologicPeptide SynthesisPeptidesPharmacologic SubstancePhosphorylationPositioning AttributePost-Translational Protein ProcessingPreparationProteinsRattusRelaxationResearchRoleSamplingSeedsSerineSideSiteSpectrum AnalysisStructureStudentsSurfaceSynapsesSystemTechniquesToxic effectTrainingTransmission Electron MicroscopyVariantVesicleWorkamyloid peptidebeta-Aspartatebrain tissuecareercytotoxicityflexibilityimprintmembrane modelneurotoxicshape analysisskillssolid statesolid state nuclear magnetic resonancestudent mentoringtoolundergraduate student
项目摘要
One of the hallmarks of Alzheimer’s disease (AD) is the presence of neurotoxic amyloid-β (Aβ) deposits in
brain tissue. All A species from oligomers to fibrils exist in a dynamic equilibrium, which is believed to
trigger a pathological cascade implicating other aggregation-prone proteins. The so-called polymorphism of
A exists at multiple levels, from the length and molecular modifications of A to the morphological
differences within the same molecular structure, to general conformational diversities and dynamics within
a single structural unit. The post-translational modifications (PTMs) have been recently implicated in
sporadic AD onset, as they are thought to trigger or accelerate the fibrillation of the wild-type A peptide
and enhance its toxicity. Further, membrane-A interactions and the resulting aggressive
oligomeric/protofibrils mixtures are increasingly implicated in elevated cytotoxicities. The long-term goal of
our research is the correlation of the intrinsic flexibility of A species with existing structural, aggregation,
and toxicitiy studies in order to pinpoint the role of conformational ensembles in promoting more
toxic/aggressive states. Having established the main features of the intrinsic flexibility of the wild-type A
fibrils, as well as the key flexibility features of the disordered N-terminal domain of several PTMs in our
previous studies, we propose to examine which features of conformational ensembles propagate into the
cross-seeded species and what other dynamical alterations are seen compared with the self-seeded wild-
type A. The goal of the proposed work is to obtain quantitative site-specific characterizations of dynamics
in the Aβ1-40 fibrils originating from the seeded growth of several strategically chosen systems: a) seeds with
PTMs of Aβ1-40 in the N-terminal region, which have been found to enhance fibrillation kinetics and
toxicities; and b) seeds produced in the presence of high concentration of synaptic plasma membrane
vesicles from rats’ brain tissues (SV). The latter can be at least partially treated within the same paradigm
as PTMs, assuming that the interactions between the SV surface and A oligomer/protofibrils/fibrils mixtures
create unique conformational ensembles that can be considered to be a “modification” analogous in its
seeding actions to PTMs with relatively aggressive aggregation propensities. We hypothesize that a range
of dynamical features propagate from the PTMs or SV seeds to the wild-type A fibrils and that these
“conserved” features may be the most important for the correlations with aggregation propensities and
cross-seeding aggressiveness. The joint investigation of the SV-A interactions and PTM cross-seeding
imprint can advance our understanding of the relationship between the amyloid fibril polymorphism and
aggregation aggressiveness, ultimately shedding light on potentially relevant pathological features. Our
main tools are static deuterium solid-state NMR and computational modeling for the assessment of the
dynamics, and transmission electron microscopy for characterization of the morphologies. The PI is
extremely committed to training undergraduate students from diverse background and proposes to train
several students in sample preparation, spectroscopy, and modeling aspects.
阿尔茨海默病(AD)的标志之一是大脑中存在神经毒性淀粉样蛋白-β(Aβ)沉积物
脑组织从低聚物到原纤维的所有A β物种都存在于动态平衡中,这被认为是
引发了一个病理性的级联反应,涉及其他易聚集的蛋白质。所谓的多态性,
A β存在于多个水平,从A β的长度和分子修饰到形态学修饰。
同一分子结构内的差异,一般构象的差异和动力学内
一个单一的结构单元。翻译后修饰(PTMs)最近已被牵连,
散发性AD发作,因为它们被认为触发或加速野生型A β肽的纤颤
并增强其毒性。此外,膜-A相互作用和由此产生的侵略性
低聚物/原纤维混合物越来越多地涉及升高的细胞毒性。的长期目标
我们的研究是A β物种的内在柔性与现有结构,聚集,
和毒性研究,以确定构象集合在促进更多
有毒/侵略性状态。在确定了野生型A β的内在灵活性的主要特征之后,
纤维,以及我们的研究中几个PTM的无序N-末端结构域的关键灵活性特征。
以前的研究,我们建议检查哪些功能的构象合奏传播到
交叉播种的物种和其他动态变化相比,自我播种的野生,
A型血吸虫所提出的工作的目标是获得定量的现场具体特征的动态
Aβ1-40原纤维来源于几种策略性选择的系统的种子生长:a)
已发现N端区域Aβ1-40的PTM可增强纤颤动力学,
毒性;和B)在高浓度突触质膜存在下产生的种子
从大鼠脑组织(SV)的囊泡。后者至少可以部分地在同一范式内处理
假设SV表面和A β寡聚体/原纤维/原纤维混合物之间的相互作用
创造独特的构象集合,可以被认为是一个“修改”类似的,
对具有相对积极的聚集倾向的PTM进行播种行动。我们假设一个范围
的动力学特征从PTM或SV种子传播到野生型A β原纤维,并且这些
“保守”特征可能是与聚集倾向相关的最重要的特征,
交叉播种的侵略性。SV-A相互作用和PTM交叉播种的联合研究
印记可以促进我们对淀粉样纤维多态性与
聚集攻击性,最终揭示潜在相关的病理特征。我们
主要工具是静态氘固态核磁共振和计算模型的评估,
动力学和用于表征形态的透射电子显微镜。主要研究者
非常致力于培养来自不同背景的本科生,并建议培养
几个学生在样品制备,光谱学和建模方面。
项目成果
期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Comparative Dynamics of Methionine Side-Chain in FMOC-Methionine and in Amyloid Fibrils.
FMOC-蛋氨酸和淀粉样原纤维中蛋氨酸侧链的比较动力学。
- DOI:10.1016/j.cplett.2017.02.021
- 发表时间:2017
- 期刊:
- 影响因子:2.8
- 作者:Vugmeyster,Liliya;Ostrovsky,Dmitry
- 通讯作者:Ostrovsky,Dmitry
Deuteron Chemical Exchange Saturation Transfer for the Detection of Slow Motions in Rotating Solids.
- DOI:10.3389/fmolb.2021.705572
- 发表时间:2021
- 期刊:
- 影响因子:5
- 作者:Vugmeyster L;Ostrovsky D;Greenwood A;Fu R
- 通讯作者:Fu R
Solvent-Driven Dynamical Crossover in the Phenylalanine Side-Chain from the Hydrophobic Core of Amyloid Fibrils Detected by 2H NMR Relaxation.
通过 2H NMR 弛豫检测到淀粉样原纤维疏水核心的苯丙氨酸侧链中溶剂驱动的动态交叉。
- DOI:10.1021/acs.jpcb.7b04726
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Vugmeyster,Liliya;Ostrovsky,Dmitry;Hoatson,GinaL;Qiang,Wei;Falconer,IsaacB
- 通讯作者:Falconer,IsaacB
Fast Motions of Key Methyl Groups in Amyloid-β Fibrils.
淀粉样β原纤维中关键甲基基团的快速运动。
- DOI:10.1016/j.bpj.2016.10.001
- 发表时间:2016
- 期刊:
- 影响因子:3.4
- 作者:Vugmeyster,Liliya;Ostrovsky,Dmitry;Clark,MatthewA;Falconer,IsaacB;Hoatson,GinaL;Qiang,Wei
- 通讯作者:Qiang,Wei
Deuterium solid-state NMR quadrupolar order rotating frame relaxation with applications to amyloid-β fibrils.
- DOI:10.1002/mrc.5114
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:Vugmeyster L;Ostrovsky D
- 通讯作者:Ostrovsky D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liliya Vugmeyster其他文献
Liliya Vugmeyster的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liliya Vugmeyster', 18)}}的其他基金
Contributions of Hydrophobic Residues into Thermodynamics and Kinetics of Amyloid
疏水残基对淀粉样蛋白热力学和动力学的贡献
- 批准号:
8758768 - 财政年份:2014
- 资助金额:
$ 46.31万 - 项目类别:
Contributions of Hydrophobic Residues into the Thermodynamics and Kinetics of Amyloid Abeta Peptide
疏水残基对 Aβ 淀粉样肽热力学和动力学的贡献
- 批准号:
9104398 - 财政年份:2014
- 资助金额:
$ 46.31万 - 项目类别:
INVESTIGATION OF DYNAMICS OF HEADPIECE PROTEINS USING NMR RELAXATION EXPERIMENTS
使用 NMR 弛豫实验研究头件蛋白质的动力学
- 批准号:
8361157 - 财政年份:2011
- 资助金额:
$ 46.31万 - 项目类别:
INVESTIGATION OF DYNAMICS OF HEADPIECE PROTEINS USING NMR RELAXATION EXPERIMENTS
使用 NMR 弛豫实验研究头件蛋白质的动力学
- 批准号:
7721654 - 财政年份:2008
- 资助金额:
$ 46.31万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 46.31万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 46.31万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 46.31万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 46.31万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 46.31万 - 项目类别: